A STUDY ON THE PREDICTORS OF MORTALITY IN ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING DYSPNEA, EOSINOPENIA, CONSOLIDATION, ACIDEMIA AND ATRIAL FIBRILLATION SCORE (DECAF)IN A TERTIARY CENTRE.
Ramdhan Somani, S. Khangarot, Anish Mittal, Qazi Faizanul Haque, Vishnu Ms, Roshni Mary Prince
{"title":"A STUDY ON THE PREDICTORS OF MORTALITY IN ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING DYSPNEA, EOSINOPENIA, CONSOLIDATION, ACIDEMIA AND ATRIAL FIBRILLATION SCORE (DECAF)IN A TERTIARY CENTRE.","authors":"Ramdhan Somani, S. Khangarot, Anish Mittal, Qazi Faizanul Haque, Vishnu Ms, Roshni Mary Prince","doi":"10.36106/gjra/2305976","DOIUrl":null,"url":null,"abstract":"Introduction Chronic Obstructive Pulmonary Disease (COPD) has emerged as one of the primary causes\nof death globally with 90% of fatalities occurring in low- and middle-income countries. It is an enormous\neconomic and social burden, with high morbidity and mortality. The DECAF score, a simple tool regularly employed by\nclinicians, is a predictive measure for in-hospital mortality and can be conveniently applied at the bedside for risk stratication\nduring Acute Exacerbations of COPD (AECOPD). Material And Methods: A cross-sectional observational study was\nconducted involving 100 patients, aged between 40 and 82 years, with a mean age of 60, who presented to the OP and IP of the\nDepartment of Respiratory Medicine. Participants who met the inclusion criteria with a diagnosis of COPD were evaluated and\ntheir data was collected. Subsequently, a DECAF score was assigned to each patient. The study then observed in-hospital\nmortality and conducted a comparative analysis of the characteristics between survivors and non-survivors. Results: The study\nincluded 100 conrmed cases of COPD, ranging from 40 to 82 years old, with a mean age of 60.66 years. A male predominance\nwas noted, as there were 77 males and 23 females in the study. An increase in the DECAF score corresponded to a higher\nutilization of ventilation. In the low-risk group (DECAF 0-1), only one patient required mechanical ventilation, while in the\nintermediate-risk group, 1 (6.25%) patient and in the high-risk group, 14 (87.5%) patients required mechanical ventilation.\nConclusion: In patients admitted with acute exacerbation of COPD, the DECAF score is a benecial clinical tool for in-hospital\nprognosis. Assessing the DECAF score after admission due to AECOPD aids in decisions regarding early escalation of care,\ntherapeutic interventions, evaluating the necessity for ICU admissions, determination of the need for assisted ventilation,\ndecision-making in end-of-life care, and provides valuable information to clinicians for informing patients and relatives about\nlife-threatening risks associated with exacerbation.","PeriodicalId":12664,"journal":{"name":"Global journal for research analysis","volume":"354 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal for research analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/gjra/2305976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction Chronic Obstructive Pulmonary Disease (COPD) has emerged as one of the primary causes
of death globally with 90% of fatalities occurring in low- and middle-income countries. It is an enormous
economic and social burden, with high morbidity and mortality. The DECAF score, a simple tool regularly employed by
clinicians, is a predictive measure for in-hospital mortality and can be conveniently applied at the bedside for risk stratication
during Acute Exacerbations of COPD (AECOPD). Material And Methods: A cross-sectional observational study was
conducted involving 100 patients, aged between 40 and 82 years, with a mean age of 60, who presented to the OP and IP of the
Department of Respiratory Medicine. Participants who met the inclusion criteria with a diagnosis of COPD were evaluated and
their data was collected. Subsequently, a DECAF score was assigned to each patient. The study then observed in-hospital
mortality and conducted a comparative analysis of the characteristics between survivors and non-survivors. Results: The study
included 100 conrmed cases of COPD, ranging from 40 to 82 years old, with a mean age of 60.66 years. A male predominance
was noted, as there were 77 males and 23 females in the study. An increase in the DECAF score corresponded to a higher
utilization of ventilation. In the low-risk group (DECAF 0-1), only one patient required mechanical ventilation, while in the
intermediate-risk group, 1 (6.25%) patient and in the high-risk group, 14 (87.5%) patients required mechanical ventilation.
Conclusion: In patients admitted with acute exacerbation of COPD, the DECAF score is a benecial clinical tool for in-hospital
prognosis. Assessing the DECAF score after admission due to AECOPD aids in decisions regarding early escalation of care,
therapeutic interventions, evaluating the necessity for ICU admissions, determination of the need for assisted ventilation,
decision-making in end-of-life care, and provides valuable information to clinicians for informing patients and relatives about
life-threatening risks associated with exacerbation.